Annual Cost Of Goods Sold
$9.89 B
+$673.60 M+7.31%
March 31, 2024
Summary
- As of February 7, 2025, TAK annual cost of goods sold is $9.89 billion, with the most recent change of +$673.60 million (+7.31%) on March 31, 2024.
- During the last 3 years, TAK annual cost of goods sold has risen by +$507.17 million (+5.41%).
- TAK annual cost of goods sold is now -1.40% below its all-time high of $10.03 billion, reached on March 31, 2020.
Performance
TAK Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cost Of Goods Sold
$2.73 B
+$78.40 M+2.95%
December 1, 2024
Summary
- As of February 7, 2025, TAK quarterly cost of goods sold is $2.73 billion, with the most recent change of +$78.40 million (+2.95%) on December 1, 2024.
- Over the past year, TAK quarterly cost of goods sold has increased by +$78.40 million (+2.95%).
- TAK quarterly cost of goods sold is now at all-time high.
Performance
TAK Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Cost Of Goods Sold
$10.45 B
+$162.99 M+1.58%
December 1, 2024
Summary
- As of February 7, 2025, TAK TTM cost of goods sold is $10.45 billion, with the most recent change of +$162.99 million (+1.58%) on December 1, 2024.
- Over the past year, TAK TTM cost of goods sold has increased by +$162.99 million (+1.58%).
- TAK TTM cost of goods sold is now at all-time high.
Performance
TAK TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cost Of Goods Sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
TAK Cost Of Goods Sold Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.3% | +3.0% | +1.6% |
| 3 y3 years | +5.4% | +16.5% | +13.6% |
| 5 y5 years | +68.2% | +14.2% | +11.4% |
TAK Cost Of Goods Sold Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.3% | at high | +23.6% | at high | +13.6% |
| 5 y | 5-year | -1.4% | +68.2% | at high | +24.0% | at high | +13.6% |
| alltime | all time | -1.4% | +313.6% | at high | +306.0% | at high | +1451.9% |
Takeda Pharmaceutical Company Limited Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $2.73 B(+3.0%) | $10.45 B(+1.6%) |
| Sep 2024 | - | $2.65 B(+6.9%) | $10.28 B(+2.8%) |
| Jun 2024 | - | $2.48 B(-3.7%) | $10.01 B(+1.4%) |
| Mar 2024 | $9.89 B(+7.3%) | $2.58 B(+0.3%) | $9.87 B(+2.4%) |
| Dec 2023 | - | $2.57 B(+8.0%) | $9.63 B(+2.0%) |
| Sep 2023 | - | $2.38 B(+1.6%) | $9.45 B(+1.8%) |
| Jun 2023 | - | $2.34 B(-0.2%) | $9.28 B(+0.9%) |
| Mar 2023 | $9.21 B(-6.6%) | $2.35 B(-1.6%) | $9.20 B(-3.3%) |
| Dec 2022 | - | $2.38 B(+7.8%) | $9.51 B(-1.0%) |
| Sep 2022 | - | $2.21 B(-2.2%) | $9.60 B(-3.0%) |
| Jun 2022 | - | $2.26 B(-14.8%) | $9.90 B(+0.6%) |
| Mar 2022 | $9.86 B(+5.1%) | $2.65 B(+7.2%) | $9.84 B(+2.7%) |
| Dec 2021 | - | $2.48 B(-1.2%) | $9.58 B(+0.5%) |
| Sep 2021 | - | $2.51 B(+13.7%) | $9.53 B(+1.6%) |
| Jun 2021 | - | $2.20 B(-7.9%) | $9.37 B(-0.1%) |
| Mar 2021 | $9.38 B(-6.5%) | $2.39 B(-1.3%) | $9.38 B(+1.2%) |
| Dec 2020 | - | $2.42 B(+3.0%) | $9.27 B(-1.6%) |
| Sep 2020 | - | $2.35 B(+6.3%) | $9.41 B(-1.7%) |
| Jun 2020 | - | $2.21 B(-2.9%) | $9.58 B(-4.4%) |
| Mar 2020 | $10.03 B(+70.6%) | $2.28 B(-11.4%) | $10.02 B(-2.7%) |
| Dec 2019 | - | $2.57 B(+2.1%) | $10.30 B(+15.0%) |
| Sep 2019 | - | $2.52 B(-5.1%) | $8.96 B(+20.5%) |
| Jun 2019 | - | $2.65 B(+3.7%) | $7.44 B(+26.3%) |
| Mar 2019 | $5.88 B(+31.3%) | $2.56 B(+108.3%) | $5.89 B(+35.3%) |
| Dec 2018 | - | $1.23 B(+23.7%) | $4.35 B(-0.7%) |
| Sep 2018 | - | $993.62 M(-10.1%) | $4.38 B(-2.3%) |
| Jun 2018 | - | $1.11 B(+8.1%) | $4.49 B(+0.4%) |
| Mar 2018 | $4.48 B(-13.4%) | $1.02 B(-18.8%) | $4.47 B(-3.4%) |
| Dec 2017 | - | $1.26 B(+14.7%) | $4.63 B(-1.9%) |
| Sep 2017 | - | $1.10 B(+1.0%) | $4.72 B(-5.7%) |
| Jun 2017 | - | $1.09 B(-8.0%) | $5.00 B(-3.2%) |
| Mar 2017 | $5.17 B(+15.9%) | $1.18 B(-12.5%) | $5.17 B(+0.6%) |
| Dec 2016 | - | $1.35 B(-2.2%) | $5.14 B(+3.2%) |
| Sep 2016 | - | $1.38 B(+10.2%) | $4.98 B(+5.7%) |
| Jun 2016 | - | $1.25 B(+8.8%) | $4.72 B(+5.7%) |
| Mar 2016 | $4.46 B | $1.15 B(-3.5%) | $4.46 B(+0.5%) |
| Dec 2015 | - | $1.19 B(+7.0%) | $4.44 B(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $1.12 B(+11.7%) | $4.46 B(-2.7%) |
| Jun 2015 | - | $998.44 M(-11.6%) | $4.59 B(-3.3%) |
| Mar 2015 | $4.76 B(-2.7%) | $1.13 B(-7.3%) | $4.74 B(-0.9%) |
| Dec 2014 | - | $1.22 B(-1.7%) | $4.79 B(-1.9%) |
| Sep 2014 | - | $1.24 B(+7.4%) | $4.88 B(+0.5%) |
| Jun 2014 | - | $1.16 B(-1.5%) | $4.85 B(-0.8%) |
| Mar 2014 | $4.89 B(-12.8%) | $1.17 B(-10.4%) | $4.89 B(-4.1%) |
| Dec 2013 | - | $1.31 B(+7.8%) | $5.10 B(-3.3%) |
| Sep 2013 | - | $1.22 B(+1.8%) | $5.28 B(-4.0%) |
| Jun 2013 | - | $1.19 B(-13.6%) | $5.49 B(-1.7%) |
| Mar 2013 | $5.61 B(+2.3%) | $1.38 B(-6.9%) | $5.59 B(-4.0%) |
| Dec 2012 | - | $1.48 B(+3.5%) | $5.82 B(-6.4%) |
| Sep 2012 | - | $1.43 B(+11.2%) | $6.22 B(+6.8%) |
| Jun 2012 | - | $1.29 B(-20.3%) | $5.82 B(+5.8%) |
| Mar 2012 | $5.49 B(+48.8%) | $1.62 B(-13.9%) | $5.50 B(+12.5%) |
| Dec 2011 | - | $1.88 B(+81.1%) | $4.89 B(+21.4%) |
| Sep 2011 | - | $1.04 B(+7.3%) | $4.03 B(+3.5%) |
| Jun 2011 | - | $967.30 M(-4.0%) | $3.89 B(+4.6%) |
| Mar 2011 | $3.69 B(+20.1%) | $1.01 B(-1.1%) | $3.72 B(+6.6%) |
| Dec 2010 | - | $1.02 B(+13.0%) | $3.49 B(+5.8%) |
| Sep 2010 | - | $901.38 M(+13.5%) | $3.30 B(+5.2%) |
| Jun 2010 | - | $794.40 M(+2.4%) | $3.14 B(+2.0%) |
| Mar 2010 | $3.07 B(+5.5%) | $776.10 M(-6.1%) | $3.07 B(+1.5%) |
| Dec 2009 | - | $826.43 M(+11.9%) | $3.03 B(+3.0%) |
| Sep 2009 | - | $738.65 M(+0.9%) | $2.94 B(+2.3%) |
| Jun 2009 | - | $732.24 M(+0.3%) | $2.87 B(+34.2%) |
| Mar 2009 | $2.91 B(+19.1%) | $730.01 M(-1.0%) | $2.14 B(+51.7%) |
| Dec 2008 | - | $737.58 M(+9.6%) | $1.41 B(+109.6%) |
| Sep 2008 | - | $673.18 M | $673.18 M |
| Mar 2008 | $2.45 B(+2.2%) | - | - |
| Mar 2007 | $2.39 B(-4.1%) | - | - |
| Mar 2006 | $2.50 B(-4.1%) | - | - |
| Mar 2005 | $2.60 B(+8.8%) | - | - |
| Mar 2004 | $2.39 B(-3.1%) | - | - |
| Mar 2003 | $2.47 B(-8.8%) | - | - |
| Mar 2002 | $2.71 B(-22.2%) | - | - |
| Mar 2001 | $3.48 B(-10.7%) | - | - |
| Mar 2000 | $3.90 B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual cost of goods sold?
- What is the all time high annual cost of goods sold for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual cost of goods sold year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly cost of goods sold year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM cost of goods sold year-on-year change?
What is Takeda Pharmaceutical Company Limited annual cost of goods sold?
The current annual cost of goods sold of TAK is $9.89 B
What is the all time high annual cost of goods sold for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual cost of goods sold is $10.03 B
What is Takeda Pharmaceutical Company Limited annual cost of goods sold year-on-year change?
Over the past year, TAK annual cost of goods sold has changed by +$673.60 M (+7.31%)
What is Takeda Pharmaceutical Company Limited quarterly cost of goods sold?
The current quarterly cost of goods sold of TAK is $2.73 B
What is the all time high quarterly cost of goods sold for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly cost of goods sold is $2.73 B
What is Takeda Pharmaceutical Company Limited quarterly cost of goods sold year-on-year change?
Over the past year, TAK quarterly cost of goods sold has changed by +$78.40 M (+2.95%)
What is Takeda Pharmaceutical Company Limited TTM cost of goods sold?
The current TTM cost of goods sold of TAK is $10.45 B
What is the all time high TTM cost of goods sold for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM cost of goods sold is $10.45 B
What is Takeda Pharmaceutical Company Limited TTM cost of goods sold year-on-year change?
Over the past year, TAK TTM cost of goods sold has changed by +$162.99 M (+1.58%)